Activist investing q1 2024 proxy battles indicate activist

Q1 2024 proxy battles indicate activist investing is reshaping healthcare sector valuations. Biotech shares hit resistance near $150, but M&A-driven momentum remains strong for activist-backed deals. I don’t get it, though. Hasn’t Netflix taken a right-wing tack recently? Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Activist investing in biotech is benefiting from FDA fast-track approvals. Targeted companies show strong upside potential if commercialization timelines shorten as per activist pressure.